SecBot SecBot
SECBOTREPLAY Home › Report › PVLA

PVLA · Director Christopher Kiritsy filed a Form 144 notice of intent to sell…

PALVELLA THERAPEUTICS, INC. · 144 filed Sep 2, 2026 at 16:10 ET

At the news

NEUTRALIMPACT 2/10

144 filed Sep 2, 2026 at 16:10 ET

Director Christopher Kiritsy filed a Form 144 notice of intent to sell 375 shares of Palvella Therapeutics, valued at approximately $58,875, from a stock option exercise. The proposed sale is immaterial relative to the company's $2.2B market cap and represents a routine insider transaction with no meaningful signal.

  • Insider: Director Christopher P. Kiritsy
  • Proposed sale: 375 shares, estimated value $58,875
  • Shares acquired via stock option exercise on the same date
  • Sale planned for 09/02/2026 on NASDAQ

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access